Next-generation therapies bring the promise of better outcomes for cancer patients. But with new discoveries come a more complex development path and more unknowns. We are here to connect your oncology program with solutions to support your success.
Your scientific breakthroughs deserve a new approach to development
By making intelligent connections, we bring innovation to the needs of today’s oncology development to help you focus on the patient, manage trial complexity, and increase predictability and speed. IQVIA helps you
Integrate biomarker strategies, operations and partners from development plans through trial execution
Design and execute adaptive and novel trial designs
Use patient insights to improve trial design, speed recruitment and reduce patient burden
Plan and execute cell and gene therapy programs with specialized expertise and resources
Optimize development plans by applying real world and commercial insights in clinical strategies and forecasting scenarios
Apply AI and machine learning to improve trial efficiency and patient safety
11 oncology approvals within 12 months
Oncology market approvals supported by IQVIA, August 2019-2020
Through advanced analytics, such as artificial intelligence and machine learning, coupled with our oncology expertise, IQVIA Oncology Commercial Solutions can help track the impact of clinical advancements in real world diagnosis and treatment patterns. By accelerating time to insights we help customers drive business decisions which, ultimately, impact patient care.
Published in Nature Reviews Drug Discovery in collaboration with Cancer Research Institute, this article provides follow up analysis on the impact of COVID-19 on oncology trials from April 2020 to March 2021.
IQVIA and Cancer Research Institute collaborated on a survey of oncology investigators and KOLs to examine the impact of the COVID-19 crises on ongoing and future oncology trials. The findings were published in this article in Nature Reviews Drug Discovery
This report looks at how cancer screening and diagnostic services were affected around the world and considers some of the actions that have been taken to tackle the difficulties – and the promise they hold for future efforts.